SCHEMBL5378678

SCHEMBL5378678

COC(=O)c1cc(S(=O)(=O)Nc2ccc(SCc3ccc(-c4ccccc4)cc3)cc2)ccc1C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.50
PLAU P00749 5/20 0.48
PABPC1 P11940 1/20 0.47
CASP6 P55212 1/20 0.46
HTT P42858 2/20 0.46
NPSR1 Q6W5P4 1/20 0.46
UCHL1 P09936 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.45
KMT2A Q03164 2/20 0.44
PLAT P00750 1/20 0.44
MCL1 Q07820 2/20 0.44
BCL2A1 Q16548 2/20 0.44
HCRTR1 O43613 1/20 0.43
LMNA P02545 2/20 0.43
GAA P10253 2/20 0.43
MAPT P10636 2/20 0.43
MEN1 O00255 1/20 0.43
RECQL P46063 1/20 0.43
ALDH1A1 P00352 1/20 0.43
ALOX15 P16050 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5373188 0.91 POLB (0.55) POLBPLAUPABPC1CASP6UCHL1
SCHEMBL5373887 0.88 POLB (0.49) POLBPABPC1CASP6HTTNPSR1
SCHEMBL5376629 0.88 CASP6 (0.52) POLBPABPC1CASP6HTTNPSR1
SCHEMBL5380693 0.88 POLB (0.62) POLBPLAUSMN1; SMN2KMT2APLAT
SCHEMBL5368231 0.88 PLAU (0.53) POLBPLAUPABPC1CASP6HTT
SCHEMBL5382317 0.86 POLB (0.51) POLBPLAUPABPC1CASP6HTT
SCHEMBL5372094 0.86 POLB (0.53) POLBPLAUPABPC1CASP6HTT
SCHEMBL5368417 0.86 ALOX15 (0.48) POLBPABPC1CASP6HTTNPSR1
SCHEMBL5382518 0.86 POLB (0.47) POLBPABPC1CASP6HTTNPSR1
SCHEMBL5380795 0.85 POLB (0.47) POLBPABPC1CASP6HTTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PFIZER INC 2006-11-16 US disclosed
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD POLB 1807/4885PLAU 3190/4885PABPC1 3612/4885
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARG, PPARA, PPARD POLB 2006/4885PLAU 3215/4885PABPC1 3461/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.